Revenue (Tables)

3 Months Ended

Dec. 31, 2020

Revenue From Contract With Customer [Abstract]

Summary of Revenues Disaggregated by Product Classification and Reportable Segment

The following table presents the Company’s revenues disaggregated by product classification and by reportable segment.

	Three Months Ended
	December 31,
(In thousands)	2020		2019
Medical Device
Product sales	$	4,561	$	5,023
Royalties		7,909		8,898
Research, development and other		2,301		2,234
License fees		1,425		1,249
Total Revenue — Medical Device		16,196		17,404
In Vitro Diagnostics
Product sales		5,541		4,952
Research, development and other		560		260
Total Revenue — In Vitro Diagnostics		6,101		5,212
Total Revenue	$	22,297	$	22,616